Assistant Professor of Medicine
Brigham and Women's Hospital
Brigham and Womens Hospital
75 Francis St
Boston MA 02115
|Coro Fellow in Public Affairs|
|Washington Univ Saint Louis||MD PhD|
|Brigham and Women's Hospital||Residency||Internal Medicine|
|Harvard Combined, (MGH, BWH, BIDMC)||Fellowship||Pulmonary and Critical Care|
1st place, 7th Annual Respiratory Disease Young Investigator Forum
AHA Young Investigator Award
AAI Young Investigator Award
AHA Cournand and Comroe Award Finalist
Fast Company: World Changing Ideas-Pandemic Response, Hon. Mention
AHA Cournand and Comroe Award Finalist (mentor)
AHA Post-doctoral fellowship (mentor)
AHA Pre-doctoral fellowship (collaborating co-mentor)
Edy Kim Lab
1) To figure out "the important stuff" in the immunology of disease by applying discovery methods (e.g., single-cell, spatial) to unique human biobanks.
2) Then validate mechanisms and therapies at the bench.
3) Then bring back to patients.
#Open positions: Looking to hire post-docs (immunology, bioinformatics, clinical/translational, bench).
#Clinical interests: I attend in the Brigham and Women's Hospital Medical Intensive Care Unit (MICU) and Pulmonary Clinic. I am Faculty Director of COVIDprotocols.org, our COVID-19 clinical guidelines.
#Research interests: Immuno-phenotyping human disease--cardiac arrest, pulmonary fibrosis (esp. rheumatoid arthritis(RA)-ILD).
#Translational: We run two clinical biobanks: The Cardiac Arrest Biobank and VATS (early lung disease biopsy) Biobank.
#Experimental: We run mouse models of cardiac arrest, sepsis and pulmonary fibrosis.
#Pharma collaboration: I lead the Biomarker/Target Discovery team in the MGB-Bayer Pulmonary Drug Discovery lab; and led the pulmonary fibrosis project in the Roche Fibroblast Network.
The research activities and funding listed below are automatically derived from
NIH ExPORTER and other sources, which might result in incorrect or missing items.
to make corrections and additions.
Jan 1, 2023 - Dec 31, 2027
Resolution of inflammation after cardiac arrest
Role Description: To define the role of immune checkpoints in clinical and experimental cardiac arrest.
Jan 1, 2023 - Dec 31, 2023
Molecular target identification in unclassifiable interstitial lung disease (ulLD)
Jul 1, 2021 - Jun 30, 2023
American Lung Association
Dalsemer Research Award in Interstitial Lung Disease (ILD): T cell-fibroblast axes drive early, unclassified ILD (uILD)
Jan 1, 2021 - Dec 31, 2023
AHA Transformational Project Award
I-CAN: A collaborative research network to discover immunological therapies for cardiac arrest
Jan 1, 2021 - Jun 30, 2021
(LEAF, DAVID EVAN)
Sep 1, 2020 - Jun 30, 2025
DEFEROXAMINE FOR THE PREVENTION OF ACUTE KIDNEY INJURY
Jan 1, 2020 - Dec 31, 2021
Brigham and Women's Hospital DOM Innovation Evergreen Fund
Discovery of novel immunological therapies for clinical cardiac arrest and resuscitation
(LEVY, MEDOFF, SILVERMAN)
Sep 20, 2019 - Sep 19, 2024
Pulmonary Drug Discovery lab
(LEAF, DAVID EVAN)
Jul 1, 2019 - Jun 30, 2023
Precision Medicine Approach to Vitamin D3 Administration in Critical Illness
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.